- call +1-201-465-4211
- email sales@mrinsights.biz
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.
Scope of the Report:
In the last several years, the development of Liposomes Drug Delivery market is fast with an average growth rate of 13.52%. In 2017, the global revenue of Liposomes Drug Delivery market is nearly 2.30 billion USD.
North America dominated the market with market share of 42.44% due to the high medical level. Following North America, Europe is the second largest market with market share of 32.33%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 23.81%.
The worldwide market for Liposome Drug Delivery (Liposomes Drug Delivery) is expected to grow at a CAGR of roughly 12.8% over the next five years, will reach 4750 million US$ in 2024, from 2600 million US$ in 2019, according to a new study.
This report focuses on the Liposome Drug Delivery (Liposomes Drug Delivery) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Gilead Sciences
Pacira
Sun Pharmaceutical
Johnson & Johnson
Luye Pharma
Sigma-Tau Group
Ipsen (Onivyde)
CSPC
Teva Pharmaceutical
Novartis
Fudan-Zhangjiang
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others
Market Segment by Applications, can be divided into
Fungal Infection Therapy
Cancer & Tumor Therapy
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Liposome Drug Delivery (Liposomes Drug Delivery) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Liposome Drug Delivery (Liposomes Drug Delivery), with price, sales, revenue and global market share of Liposome Drug Delivery (Liposomes Drug Delivery) in 2017 and 2018.
Chapter 3, the Liposome Drug Delivery (Liposomes Drug Delivery) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Liposome Drug Delivery (Liposomes Drug Delivery) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Liposome Drug Delivery (Liposomes Drug Delivery) market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Liposome Drug Delivery (Liposomes Drug Delivery) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Liposome Drug Delivery (Liposomes Drug Delivery) Introduction
1.2 Market Analysis by Type
1.2.1 Liposomal Doxorubicin
1.2.2 Liposomal Amphoteracin B
1.2.3 Liposomal Paclitaxel
1.2.4 Others
1.3 Market Analysis by Applications
1.3.1 Fungal Infection Therapy
1.3.2 Cancer & Tumor Therapy
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Gilead Sciences
2.1.1 Business Overview
2.1.2 Liposome Drug Delivery (Liposomes Drug Delivery) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Gilead Sciences Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Pacira
2.2.1 Business Overview
2.2.2 Liposome Drug Delivery (Liposomes Drug Delivery) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Pacira Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Sun Pharmaceutical
2.3.1 Business Overview
2.3.2 Liposome Drug Delivery (Liposomes Drug Delivery) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Sun Pharmaceutical Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Johnson & Johnson
2.4.1 Business Overview
2.4.2 Liposome Drug Delivery (Liposomes Drug Delivery) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Johnson & Johnson Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Luye Pharma
2.5.1 Business Overview
2.5.2 Liposome Drug Delivery (Liposomes Drug Delivery) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Luye Pharma Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Sigma-Tau Group
2.6.1 Business Overview
2.6.2 Liposome Drug Delivery (Liposomes Drug Delivery) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sigma-Tau Group Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Ipsen (Onivyde)
2.7.1 Business Overview
2.7.2 Liposome Drug Delivery (Liposomes Drug Delivery) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Ipsen (Onivyde) Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 CSPC
2.8.1 Business Overview
2.8.2 Liposome Drug Delivery (Liposomes Drug Delivery) Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 CSPC Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Teva Pharmaceutical
2.9.1 Business Overview
2.9.2 Liposome Drug Delivery (Liposomes Drug Delivery) Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Teva Pharmaceutical Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Novartis
2.10.1 Business Overview
2.10.2 Liposome Drug Delivery (Liposomes Drug Delivery) Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Novartis Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Fudan-Zhangjiang
2.11.1 Business Overview
2.11.2 Liposome Drug Delivery (Liposomes Drug Delivery) Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Fudan-Zhangjiang Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Liposome Drug Delivery (Liposomes Drug Delivery) Manufacturer Market Share in 2018
3.3.2 Top 6 Liposome Drug Delivery (Liposomes Drug Delivery) Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Analysis by Regions
4.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue and Market Share by Regions
4.1.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Market Share by Regions (2014-2019)
4.1.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue and Market Share by Regions (2014-2019)
4.2 North America Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2014-2019)
4.3 Europe Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2014-2019)
4.5 South America Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2014-2019)
5 North America Liposome Drug Delivery (Liposomes Drug Delivery) by Country
5.1 North America Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue and Market Share by Country
5.1.1 North America Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Market Share by Country (2014-2019)
5.1.2 North America Liposome Drug Delivery (Liposomes Drug Delivery) Revenue and Market Share by Country (2014-2019)
5.2 United States Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2014-2019)
5.3 Canada Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2014-2019)
5.4 Mexico Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2014-2019)
6 Europe Liposome Drug Delivery (Liposomes Drug Delivery) by Country
6.1 Europe Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue and Market Share by Country
6.1.1 Europe Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Market Share by Country (2014-2019)
6.1.2 Europe Liposome Drug Delivery (Liposomes Drug Delivery) Revenue and Market Share by Country (2014-2019)
6.2 Germany Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2014-2019)
6.3 UK Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2014-2019)
6.4 France Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2014-2019)
6.5 Russia Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2014-2019)
6.6 Italy Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2014-2019)
7 Asia-Pacific Liposome Drug Delivery (Liposomes Drug Delivery) by Country
7.1 Asia-Pacific Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Liposome Drug Delivery (Liposomes Drug Delivery) Revenue and Market Share by Country (2014-2019)
7.2 China Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2014-2019)
7.3 Japan Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2014-2019)
7.4 Korea Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2014-2019)
7.5 India Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2014-2019)
8 South America Liposome Drug Delivery (Liposomes Drug Delivery) by Country
8.1 South America Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue and Market Share by Country
8.1.1 South America Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Market Share by Country (2014-2019)
8.1.2 South America Liposome Drug Delivery (Liposomes Drug Delivery) Revenue and Market Share by Country (2014-2019)
8.2 Brazil Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2014-2019)
8.3 Argentina Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2014-2019)
8.4 Colombia Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2014-2019)
9 Middle East and Africa Liposome Drug Delivery (Liposomes Drug Delivery) by Countries
9.1 Middle East and Africa Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Liposome Drug Delivery (Liposomes Drug Delivery) Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2014-2019)
9.3 Turkey Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2014-2019)
9.4 Egypt Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2014-2019)
9.5 Nigeria Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2014-2019)
9.6 South Africa Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Growth Rate (2014-2019)
10 Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Segment by Type
10.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Sales and Market Share by Type (2014-2019)
10.1.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue and Market Share by Type (2014-2019)
10.2 Liposomal Doxorubicin Sales Growth and Price
10.2.1 Global Liposomal Doxorubicin Sales Growth (2014-2019)
10.2.2 Global Liposomal Doxorubicin Price (2014-2019)
10.3 Liposomal Amphoteracin B Sales Growth and Price
10.3.1 Global Liposomal Amphoteracin B Sales Growth (2014-2019)
10.3.2 Global Liposomal Amphoteracin B Price (2014-2019)
10.4 Liposomal Paclitaxel Sales Growth and Price
10.4.1 Global Liposomal Paclitaxel Sales Growth (2014-2019)
10.4.2 Global Liposomal Paclitaxel Price (2014-2019)
10.5 Others Sales Growth and Price
10.5.1 Global Others Sales Growth (2014-2019)
10.5.2 Global Others Price (2014-2019)
11 Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Segment by Application
11.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Sales Market Share by Application (2014-2019)
11.2 Fungal Infection Therapy Sales Growth (2014-2019)
11.3 Cancer & Tumor Therapy Sales Growth (2014-2019)
11.4 Others Sales Growth (2014-2019)
12 Liposome Drug Delivery (Liposomes Drug Delivery) Market Forecast (2019-2024)
12.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue and Growth Rate (2019-2024)
12.2 Liposome Drug Delivery (Liposomes Drug Delivery) Market Forecast by Regions (2019-2024)
12.2.1 North America Liposome Drug Delivery (Liposomes Drug Delivery) Market Forecast (2019-2024)
12.2.2 Europe Liposome Drug Delivery (Liposomes Drug Delivery) Market Forecast (2019-2024)
12.2.3 Asia-Pacific Liposome Drug Delivery (Liposomes Drug Delivery) Market Forecast (2019-2024)
12.2.4 South America Liposome Drug Delivery (Liposomes Drug Delivery) Market Forecast (2019-2024)
12.2.5 Middle East and Africa Liposome Drug Delivery (Liposomes Drug Delivery) Market Forecast (2019-2024)
12.3 Liposome Drug Delivery (Liposomes Drug Delivery) Market Forecast by Type (2019-2024)
12.3.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Sales Forecast by Type (2019-2024)
12.3.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Share Forecast by Type (2019-2024)
12.4 Liposome Drug Delivery (Liposomes Drug Delivery) Market Forecast by Application (2019-2024)
12.4.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Sales Forecast by Application (2019-2024)
12.4.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Liposome Drug Delivery (Liposomes Drug Delivery) Picture
Table Product Specifications of Liposome Drug Delivery (Liposomes Drug Delivery)
Figure Global Sales Market
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
